MacLean F, Tsegaye A, Graham J, Swarts J, Vick S, Potchen N
bioRxiv. 2024; .
PMID: 39005354
PMC: 11245000.
DOI: 10.1101/2024.07.03.601916.
Chinunga T, Chahroudi A, Ribeiro S
Curr Opin HIV AIDS. 2024; 19(4):201-211.
PMID: 38841850
PMC: 11155294.
DOI: 10.1097/COH.0000000000000857.
Cotugno N, Neri A, Sanna M, Santilli V, Manno E, Pascucci G
JCI Insight. 2024; 9(10).
PMID: 38775152
PMC: 11141905.
DOI: 10.1172/jci.insight.177182.
Alcami J, Joseph Munne J, Munoz-Fernandez M, Esteban M
Enferm Infecc Microbiol Clin. 2024; 23:15-24.
PMID: 38620211
PMC: 7130212.
DOI: 10.1016/S0213-005X(05)75157-0.
Hamadani C, Mahdi F, Merrell A, Flanders J, Cao R, Vashisth P
Adv Sci (Weinh). 2024; 11(23):e2305484.
PMID: 38572510
PMC: 11186118.
DOI: 10.1002/advs.202305484.
Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention.
Tarres-Freixas F, Clotet B, Carrillo J, Blanco J
Vaccines (Basel). 2024; 12(3).
PMID: 38543932
PMC: 10975260.
DOI: 10.3390/vaccines12030298.
Computationally inferred cell-type specific epigenome-wide DNA methylation analysis unveils distinct methylation patterns among immune cells for HIV infection in three cohorts.
Zhang X, Hu Y, Vandenhoudt R, Yan C, Marconi V, Cohen M
PLoS Pathog. 2024; 20(3):e1012063.
PMID: 38466776
PMC: 10957090.
DOI: 10.1371/journal.ppat.1012063.
Immunologic and Virologic Parameters Associated With Human Immunodeficiency Virus (HIV) DNA Reservoir Size in People With HIV Receiving Antiretroviral Therapy.
Blazkova J, Whitehead E, Schneck R, Shi V, Justement J, Rai M
J Infect Dis. 2023; 229(6):1770-1780.
PMID: 38128541
PMC: 11492273.
DOI: 10.1093/infdis/jiad595.
Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application.
Tao N, Xu X, Ying Y, Hu S, Sun Q, Lv G
Molecules. 2023; 28(8).
PMID: 37110771
PMC: 10144173.
DOI: 10.3390/molecules28083539.
Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV.
Hamadani C, Mahdi F, Merrell A, Flanders J, Cao R, Vashisth P
Res Sq. 2023; .
PMID: 36824802
PMC: 9949257.
DOI: 10.21203/rs.3.rs-2574352/v1.
CD8 Encephalitis in HIV: A Review of This Emerging Entity.
Shenoy A, Kaur Marwaha P, Worku D
J Clin Med. 2023; 12(3).
PMID: 36769419
PMC: 9917721.
DOI: 10.3390/jcm12030770.
Role of CXCR5 CD8 T cells in human immunodeficiency virus-1 infection.
Gao L, Zhou J, Ye L
Front Microbiol. 2022; 13:998058.
PMID: 36452930
PMC: 9701836.
DOI: 10.3389/fmicb.2022.998058.
The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection.
Anikeeva N, Steblyanko M, Kuri-Cervantes L, Buggert M, Betts M, Sykulev Y
Nat Commun. 2022; 13(1):6436.
PMID: 36307445
PMC: 9616955.
DOI: 10.1038/s41467-022-34157-0.
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design.
Zhang H, He C, Jiang F, Cao S, Zhao B, Ding H
BMC Immunol. 2022; 23(1):15.
PMID: 35366796
PMC: 8976269.
DOI: 10.1186/s12865-022-00491-7.
Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective.
Ndondo A, Eley B, Wilmshurst J, Kakooza-Mwesige A, Giannoccaro M, Willison H
Front Immunol. 2022; 13:833548.
PMID: 35356001
PMC: 8959857.
DOI: 10.3389/fimmu.2022.833548.
Quantification of Oral Candidal Carriage Rate and Prevalence of Oral Candidal Species in HIV Patients with and Without Highly Active Antiretroviral Therapy.
Perla N, Kumar S, Jadhav A, Bhalinge P, Dadpe M, Acharya S
J Microsc Ultrastruct. 2022; 9(4):145-153.
PMID: 35070688
PMC: 8751674.
DOI: 10.4103/JMAU.JMAU_32_19.
Therapeutic Potential of IL-15 and N-803 in HIV/SIV Infection.
Harwood O, OConnor S
Viruses. 2021; 13(9).
PMID: 34578331
PMC: 8473246.
DOI: 10.3390/v13091750.
Monophosphoryl Lipid A and Poly I:C Combination Adjuvant Promoted Ovalbumin-Specific Cell Mediated Immunity in Mice Model.
Ahn S, Le C, Ko E
Biology (Basel). 2021; 10(9).
PMID: 34571785
PMC: 8471534.
DOI: 10.3390/biology10090908.
A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients.
Hassaniazad M, Eftekhar E, Rahnama Inchehsablagh B, Kamali H, Tousi A, Jaafari M
Phytother Res. 2021; 35(11):6417-6427.
PMID: 34541720
PMC: 8661812.
DOI: 10.1002/ptr.7294.
Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.
Ding C, Patel D, Ma Y, Mann J, Wu J, Gao Y
Front Immunol. 2021; 12:697683.
PMID: 34354709
PMC: 8329590.
DOI: 10.3389/fimmu.2021.697683.